Asia Pacific Insulin Pens Market to Reach US$ 1,703.7 Mn at CAGR of 9.8% in 2027 | The Insight Partners

Asia Pacific Insulin Pens Market to 2027 - Regional Analysis and Forecasts by Product Type (Disposable and Reusable); Application (Diabetes Type-1 and Diabetes Type-2); Distribution Channel (Hospital Pharmacies, Retail Pharmacies and e-Commerce) and Geography

Publication Month: Aug 2019 | Report Code: TIPRE00006392 | No. of Pages: 120 | Category: Medical Device | Status: Published

The Asia Pacific insulin pen market is expected to reach US$ 1,703.7 Mn in 2027 from US$ 743.4 Mn in 2018. The market is estimated to grow with a CAGR of 9.8% from 2019-2027.

 

The growth of the market is driven by the factors such as, growing geriatric population, increasing rate of obesity and rising incidence of diabetes. However, the market is likely to get impacted due to availability of alternatives for drug delivery and limitations associated with insulin pens in the region.

 

Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two types of diabetes namely diabetes type-I also known as diabetes insipid us and diabetes type-II also termed as diabetes mellitus. Incidences and prevalence of diabetes is steadily increasing across the globe. Type 2 diabetes is the most prevalent form of diabetes and has increased alongside cultural and societal changes. In high-income countries up to 91% of adults with the disease have type 2 diabetes.

According to the International Diabetes Federation estimated that there were 382 million people with diabetes in 2013, a number exceeding its earlier predictions. Here, more than 60% of the people with diabetes live in Asia, with almost one-half in China and India combined. The Western Pacific is the world’s most populous region, has more than 138.2 million people with diabetes, and the number may rise to 201.8 million by 2035.


PREVALENCE OF DIABETES WORLDWIDE, 2017

Country

People with Diabetes

China

114,394.82

Japan

7,234.23

India

72,946.39

                       Source: International Diabetes Federation

 

Diabetes of all types can lead to various complications in many parts of the body and can increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss and nerve damage are the major complications associated with this disease.

Patients suffering from diabetes require frequent monitoring and external administration of insulin that is given through insulin pens and other medical devices. The rising prevalence of diabetes across the globe is expected to drive the growth of the insulin pens market worldwide during the forecast period.

 

China is expected to lead the market in the Asia Pacific region owing to highest rate of incidences for the type 2 diabetes and increasing awareness in the country. However, rise in the prevalence of the diabetes is likely to add novel opportunities in the forecast period. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.

 

 

 

 

ASIA PACIFIC DIABETES CARE DEVICES – MARKET SEGMENTATION

By Product

  • Disposable
  • Reusable

By End User

  • Diabetes Type-1
  • Diabetes Type-2

 

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce

 

By Geography

  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia

Company Profiles

  • Owen Mumford, LTD.
  • Novo Nordisk a/s
  • Companion Medical
  • Berlin-Chemie AG
  • Pendiq GmbH
  • Emperra GmbH E-Health Technologies
  • Eli lilly and company
  • Ypsomed Ag
  • SANOFI
  • Biocon

Part 1.Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

Part 2.North America Diabetes Care Devices Market – Key Takeaways

Part 3.North America Diabetes Care Devices Market – Market Landscape

3.1       Overview

3.2       Market segmentation

3.2.1       North America Diabetes Care Devices Market – By Product

3.2.2       North America Diabetes Care Devices Market – By End USer

3.2.3       North America Diabetes Care Devices Market – By Country

3.3       PEST Analysis

Part 4.North America Diabetes Care Devices Market - Key Market Dynamics

4.1       Key Market Drivers

4.1.1       Growing Geriatric Population

4.1.2       Rapid Technological Advancements in Diabetes Care Devices

4.2       Key Market Restraints

4.2.1       High Cost of Diabetes Care Devices

4.2.2       Risks Associated with the Insulin Delivery Devices

4.3       Key Market Opportunities

4.3.1       Development of Cost Efficient Pen Needles

4.4       future Trends

4.4.1       Growing Product Innovations

4.5       Impact analysis

Part 5.Diabetes Care Devices Market – North America Analysis

5.1       North America DIABETES CARE DEVICES market Revenue Forecasts and Analysis

5.2       Market positioning

5.3       PERFORMANCE OF KEY PLAYERS

5.3.1       Medtronic

5.3.2       F. Hoffmann-La Roche Ltd.

Part 6.North America Diabetes Care Devices Market Analysis – By Product

6.1       overview

6.2       North America diabetes care devices Market BY Product, 2018 & 2027 (%)

6.3       North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)

6.3.1       North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

6.3.2       North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

6.4       Glucose Monitoring Devices Market

6.4.1       Overview

6.4.2       North America Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.4.3       Glucometers Market

6.4.3.1    Overview

6.4.3.2    North America Glucometers Market Revenue and Forecast to 2027 (US$ Mn)

6.4.4       Lancets Market

6.4.4.1    Overview

6.4.4.2    North America Lancets Market Revenue and Forecast to 2027 (US$ Mn)

6.4.5       Testing Strips Market

6.4.5.1    Overview

6.4.5.2    North America Testing Strips Market Revenue and Forecast to 2027 (US$ Mn)

6.4.6       Other Glucose Monitoring Devices Market

6.4.6.1    Overview

6.4.6.2    North America Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.5       Insulin Delivery Devices Market

6.5.1       Overview

6.5.2       North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.5.3       Insulin Pens Market

6.5.3.1    Overview

6.5.3.2    North America Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn)

6.5.4       Insulin Syringes Market

6.5.4.1    Overview

6.5.4.2    North America Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn)

6.5.5       Insulin Pumps Market

6.5.5.1    Overview

6.5.5.2    North America Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn)

6.5.6       Other Insulin Delivery Devices Market

6.5.6.1    Overview

6.5.6.2    North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

Part 7.North America Diabetes Care Devices Market Analysis – By End USer

7.1       Overview

7.2       NORTH AMERICA DIABETES CARE DEVICES MARKET, BY End USer, 2018 & 2027 (%)

7.3       North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)

7.4       Homecare MArket

7.4.1       Overview

7.4.2       North America Homecare Market Revenue and Forecasts to 2027 (US$ Mn)

7.5       Hospitals & Clinics Market

7.5.1       Overview

7.5.2       North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

Part 8.North America Diabetes Care Devices Market Revenue And Forecasts To 2027

8.1       Overview

8.2       North America DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)

8.3       North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.3.1       North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.2       North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4       North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)

8.5       North America Diabetes care devices Market Revenue And Forecasts to 2027, By Country (%)

8.6       US DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)

8.6.1       US Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.2       US Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.6.2.1    US Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.6.2.2    US Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.6.3       US Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

8.7       Canada Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.7.1       Canada Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.7.2       Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.7.2.1    Canada Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.7.2.2    Canada Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.7.3       Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

8.8       Mexico Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.8.1       Mexico Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.8.2       Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.8.2.1    Mexico Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.8.2.2    Mexico Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.8.3       Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

Part 9.Diabetes Care Devices Market – Industry Landscape

9.1       Overview

9.2       Comparative Company Analysis

9.3       Growth Strategies done by the companies in the Market, (%)

9.4       Organic Developments

9.4.1       Overview

9.5       Inorganic developments

9.5.1       Overview

Part 10.Diabetes Care Devices Market–Key Company Profiles

10.1    BD

10.1.1    Key Facts

10.1.2    Business Description

10.1.3    Financial Overview

10.1.4    Product Portfolio

10.1.5    SWOT Analysis

10.1.6    Key Developments

10.2    novo nordisk a/s

10.2.1    Key Facts

10.2.2    Business Description

10.2.3    Financial Overview

10.2.4    Product Portfolio

10.2.5    SWOT Analysis

10.2.6    Key Developments

10.3    B. Braun Melsungen AG

10.3.1    Key Facts

10.3.2    Business Description

10.3.3    Financial Overview

10.3.4    Product Portfolio

10.3.5    SWOT Analysis

10.3.6    Key Developments

10.4    Medtronic

10.4.1    Key Facts

10.4.2    Business Description

10.4.3    Financial Information

10.4.4    Product Portfolio

10.4.5    SWOT Analysis

10.4.6    Key Developments

10.5    Tandem Diabetes Care, Inc.

10.5.1    Key Facts

10.5.2    Business Description

10.5.3    Financial Information

10.5.4    Product Portfolio

10.5.5    SWOT Analysis

10.5.6    Key Developments

10.6    Insulet Corporation

10.6.1    Key Facts

10.6.2    Business Description

10.6.3    Financial Information

10.6.4    Product Portfolio

10.6.5    SWOT Analysis

10.6.6    Key Developments

10.7    Eli lilly and company

10.7.1    Key Facts

10.7.2    Business Description

10.7.3    Financial Overview

10.7.4    Product Portfolio

10.7.5    SWOT Analysis

10.7.6    Key Developments

10.8    Dexcom, Inc.

10.8.1    Key Facts

10.8.2    Business Description

10.8.3    Financial Overview

10.8.4    Product Portfolio

10.8.5    SWOT Analysis

10.8.6    Key Developments

10.9    Terumo Corporation

10.9.1    Key Facts

10.9.2    Business Description

10.9.3    Financial Overview

10.9.4    Product portfolio

10.9.5    SWOT ANALYSIS

10.9.6    KEY DEVELOPMENTS

10.10  F. Hoffmann-La Roche Ltd.

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Financial Overview

10.10.4 Product Portfolio

10.10.5 SWOT Analysis

10.10.6 Key Developments

Part 11.Appendix

11.1    About The Insight Partners

11.2    Glossary of Terms

11.3    Methodology

11.3.1    Coverage

11.3.2    Secondary Research

11.3.3    Primary Research

LIST OF TABLES

Table 1.            Total Number Of Persons Ofaged 60 Years Or Above By Region, 2017 & 2050

Table 2.            North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 3.            North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 4.            North America Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 5.            North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 6.            North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 7.            North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 8.            North America Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 9.            North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 10.         US Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 11.         US Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 12.         US Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 13.         US Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 14.         Canada Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 15.         Canada Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 16.         Canada Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 17.         Canada Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 18.         Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 19.         Mexico Glucose Monitoring Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 20.         Mexico Insulin Delivery Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 21.         Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027, By End USer (US$ Mn)

Table 22.         Organic Developments Done By Companies

Table 23.         Inorganic Developments Done By Companies

Table 24.         Glossary Of Terms, Diabetes Care Devices Market

LIST OF FIGURES

Figure 1.          US Diabetes Care Devices Market, Revenue (US$ Mn), By Country 2018 & 2027

Figure 2.          North America Diabetes Care Devices Market By Product, Market Share (%), 2018

Figure 3.          North America Diabetes Care Devices Market By End USer, Market Share (%), 2018

Figure 4.          Diabetes Care Devices Market Segmentation

Figure 5.          North America Pest Analysis

Figure 6.          Diabetes Care Devices Market Impact Analysis Of Drivers & Restraints

Figure 7.          North America Diabetes Care Devices Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 8.          North America Diabetes Care Devices Market, By Product 2018 & 2027 (%)

Figure 9.          North America Glucose Monitoring Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 10.       North America Glucometers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 11.       North America Lancets Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 12.       North America Testing Strips Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13.       North America Other Glucose Monitoring Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.       North America Insulin Delivery Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 15.       North America Insulin Pens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.       North America Insulin Syringes Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17.       North America Insulin Pumps Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 18.       North America Insulin Delivery Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       North America Diabetes Care Devices Market By End USer, 2018 & 2027 (%)

Figure 20.       North America Homecare Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 21.       North America Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.       North America Diabetes Care Devices Market Revenue Overview, By Country, 2018 (US$ Mn)

Figure 23.       North America Diabetes Care Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       North America Diabetes Care Devices Market Revenue And Forecasts To 2027, By Country (%)

Figure 25.       US Diabetes Care Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26.       Canada Diabetes Care Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 27.       Mexico Diabetes Care Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 28.       Comparative Company Analysis

Figure 29.       Growth Strategies Done By The Companies In The Market, (%)

 

The List of Companies

  1. Owen Mumford, LTD.
  2. Novo Nordisk a/s
  3. Companion Medical
  4. Berlin-Chemie AG
  5. Pendiq GmbH
  6. Emperra GmbH E-Health Technologies
  7. Eli lilly and company
  8. Ypsomed Ag
  9. SANOFI
  10. Biocon